Peptide record

TPDB10959

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10959
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 27-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GGLRSLGRKILRAWKKYGPQATPATRQ
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C134H225N45O34
NDCEHMFV
RG
3010.54
12.42
7
0
9
+7
2.40
-0.911
68.89
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
6990
2.32
6
Residue Composition
number
3
A
4
R
0
N
0
D
0
C
0
E
2
Q
4
G
0
H
1
I
3
L
3
K
0
M
0
F
2
P
1
S
2
T
1
W
1
Y
0
V
Amino Acid Distribution
A: 3 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 4 H: 0 I: 1 L: 3 K: 3 M: 0 F: 0 P: 2 S: 1 T: 2 W: 1 Y: 1 V: 0
Chemical Descriptors
27 reviewed residue count
C134H225N45O34 sequence-only estimate (linear, free termini)
3010.54 sequence-only estimate (linear, free termini)
12.42 sequence-only estimate (linear, free termini)
+7 sequence-only estimate (linear, free termini)
2.40 sequence-only estimate (linear, free termini)
-0.911 sequence-only estimate (linear, free termini)
Evidence Records 28 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.5-1 µM

Target

Escherichia coli ATCC 25922 ML-35

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcesce
Evidence 2 Activity

Activity

MIC
Antibacterial
1 µM

Target

S. typhimurium ATCC 14028

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATC
Evidence 3 Activity

Activity

MIC
Antibacterial
0.5 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP

Other

ve against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S.
Evidence 4 Activity

Activity

MIC
Antibacterial
4 µM

Target

S. marcescens ATCC 8100

Source & Reference

dbAMP DRAMP

Other

C 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B
Evidence 5 Activity

Activity

MIC
Antibacterial
8 µM

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP DRAMP

Other

28 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C.
Evidence 6 Activity

Activity

MIC
Antibacterial
2 µM

Target

Staphylococcus epidermidis ATCC 12228

Source & Reference

dbAMP DRAMP

Other

uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 7 Activity

Activity

MIC
Antibacterial
2 µM

Target

B. megaterium Bm11

Source & Reference

dbAMP DRAMP

Other

), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 8 Activity

Activity

MIC
Antibacterial
8 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 9 Activity

Activity

MIC
Antibacterial
4 µM

Target

C. neoformans

Source & Reference

dbAMP DRAMP

Other

ermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 10 Activity

Activity

MIC
Antifungal
0.5-1 µM

Target

Escherichia coli ATCC 25922 ML-35

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcesce
Evidence 11 Activity

Activity

MIC
Antifungal
1 µM

Target

S. typhimurium ATCC 14028

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATC
Evidence 12 Activity

Activity

MIC
Antifungal
0.5 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ve against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S.
Evidence 13 Activity

Activity

MIC
Antifungal
4 µM

Target

S. marcescens ATCC 8100

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

C 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B
Evidence 14 Activity

Activity

MIC
Antifungal
8 µM

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

28 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C.
Evidence 15 Activity

Activity

MIC
Antifungal
2 µM

Target

Staphylococcus epidermidis ATCC 12228

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 16 Activity

Activity

MIC
Antifungal
2 µM

Target

B. megaterium Bm11

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 17 Activity

Activity

MIC
Antifungal
8 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 18 Activity

Activity

MIC
Antifungal
4 µM

Target

C. neoformans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 19 Activity

Activity

MIC
Antiparasitic
0.5-1 µM

Target

Escherichia coli ATCC 25922 ML-35

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcesce
Evidence 20 Activity

Activity

MIC
Antiparasitic
1 µM

Target

S. typhimurium ATCC 14028

Source & Reference

DRAMP

Other

Active against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATC
Evidence 21 Activity

Activity

MIC
Antiparasitic
0.5 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

DRAMP

Other

ve against E. coli ATCC 25922 ML-35 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S.
Evidence 22 Activity

Activity

MIC
Antiparasitic
4 µM

Target

S. marcescens ATCC 8100

Source & Reference

DRAMP

Other

C 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B
Evidence 23 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Staphylococcus aureus ATCC 25923

Source & Reference

DRAMP

Other

28 (MIC 1 uM), P. aeruginosa ATCC 27853 (MIC 0.5 uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C.
Evidence 24 Activity

Activity

MIC
Antiparasitic
2 µM

Target

Staphylococcus epidermidis ATCC 12228

Source & Reference

DRAMP

Other

uM), S. marcescens ATCC 8100 (MIC 4 uM), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 25 Activity

Activity

MIC
Antiparasitic
2 µM

Target

B. megaterium Bm11

Source & Reference

DRAMP

Other

), S. aureus ATCC 25923 (MIC 8 uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 26 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

uM) but MRSA >64 uM, S. epidermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 27 Activity

Activity

MIC
Antiparasitic
4 µM

Target

C. neoformans

Source & Reference

DRAMP

Other

ermidis ATCC 12228 (MIC 2 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 8 uM), and C. neoformans (MIC 4 uM).
Evidence 28 Activity

Activity

3% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
3% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. | J Biol Chem | 1996